Elsevier Appoints Industry Leader Omry Bigger as President of its Global Clinical Solutions Business Unit

Elsevier Health, a global leader in medical information and data analytics, today announced the appointment of Mr. Omry Bigger as President, Clinical Solutions at Elsevier Health. He joins Elsevier from LexisNexis Legal & Professional, another part of RELX, a leading global provider of information-based analytic tools.

Omry brings over 14 years of leadership experience from LexisNexis Legal & Professional, where he served as SVP, Large Markets at LexisNexis North America.

Notably, Omry played a pivotal role in the successful commercial roll-out of Lexis+ AI, the first Generative AI offering across RELX. Under Omry’s leadership, the Clinical Solutions business will aim to further strengthen its portfolio of trusted products supporting clinicians across the world, including the recently launched ClinicalKey AI.

Jan Herzhoff, President of Elsevier Health said: “With his extensive expertise in commercial go-to-market activities, highly competitive markets, and generative AI, Omry is well-equipped to lead Elsevier's Clinical Solutions business toward accelerated growth. His deep understanding of customer needs and his ability to deliver innovative solutions will be invaluable as we continue to enhance our portfolio and drive growth.”

Commenting on his appointment, Omry said: “I am delighted to be joining Elsevier Health at such an exciting time for the business. We are well positioned to take advantage of the many opportunities provided by AI in healthcare, and I look forward in working with the highly skilled and dedicated Clinical Solutions team to deliver exceptional value to customers, and ultimately, to improve patient outcomes.”

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。